Table 1.
The clinical characteristics of patients in AR group, ATN group and control group
| Group | Control | AR | ATN |
|---|---|---|---|
| Case number | 35 | 10 | 5 |
| Age (years) | 34.6 ± 10.1 | 36.3 ± 9.2 | 37.6 ± 11.5 |
| Male: Female | 28:7 | 6:4 | 4:1 |
| Post-operation days | 12.7 ± 6.4 | 31.1 ± 44.5* | 12.0 ± 5.3 |
| Post-biopsy days | NA | 1.1 ± 3.9 | 1.4 ± 3.4 |
| Urine output (l/24 hours) | 2.36 ± 0.44 | 1.67 ± 0.96* | 1.40 ± 0.66* |
| sCr (μmol/l) | 88.8 ± 21.9 | 256.3 ± 173.5* | 322.8 ± 179.1* |
| Hb (g/l) | 104.2 ± 15.7 | 88.6 ± 15.1* | 81.8 ± 14.4* |
| MAP (mmHg) | 95.3 ± 10.9 | 109.9 ± 11.2* | 107.7 ± 15.6* |
| Tacrolimus: CsA | 30:5 | 6:4 | 5:0 |
| Tacrolimus trough concentration (ng/ml) | 7.5 ± 1.6 | 8.4 ± 2.4# | 4.8 ± 1.6* |
| CsA trough concentration (ng/ml) | 320.5 ± 64.8 | 238.6 ± 89.6 | NA |
Note: sCr, serum creatinine; Hb, hemoglobin; MAP, mean arterial pressure; CsA, cyclosporine A; NA, not applicable. *p < 0.05 compared with the control group;#p < 0.05 compared with the ATN group.